The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity
N = 36
- Population
- Patients with nonmetastatic high-grade osteosarcoma of the extremity after definitive surgery
- Design
- Randomised controlled trial with concurrent controls: after definitive surgery, 36 patients were randomly assigned to intensive multi-agent adjuvant chemotherapy or to observation. 77 additional patients who declined randomisation chose observation or chemotherapy and were reported alongside.
- Arms
- Observation (control): No adjuvant treatment after surgery
- Adjuvant chemotherapy (experimental): Intensive multi-agent adjuvant chemotherapy (agents not named in the abstract)
- People
- Link MP
Δ 24-month RFS+49 points
Show the numbers
| Endpoint | Analysis | Adjuvant chemotherapy | Observation | Effect |
|---|---|---|---|---|
| RFSPatients randomised after definitive surgery (36) | primaryLink 1986 | 66% at 2 y | 17% at 2 y | P<0.001Two-year actuarial relapse-free survival. Similar results were reported in 77 additional non-randomised patients. |
| Endpoint | Analysis | Adjuvant chemotherapy | Observation | Effect |
|---|---|---|---|---|
| RFSPatients randomised after definitive surgery (36) | primaryLink 1986 | 66% at 2 y | 17% at 2 y | P<0.001Two-year actuarial relapse-free survival. Similar results were reported in 77 additional non-randomised patients. |